A High Affinity Nanobody Against Endothelin Receptor Type B: A New Approach to the Treatment of Melanoma
Molecular Biology Reports - Netherlands
doi 10.1007/s11033-020-05313-w
Full Text
Open PDFAbstract
Available in full text
Date
February 20, 2020
Authors
Publisher
Springer Science and Business Media LLC